GU Podcast (2020): The Expanding Role Of Immune Checkpoint Inhibitors In MIBC And NMIBC
AUAUniversity
English - October 21, 2020 05:00 - 35 minutes - 32.8 MB - ★★★★★ - 32 ratingsCourses Education Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: GU Podcast 2020 - Advanced Prostate Cancer - AUA ASTRO SUO Guideline Podcast Part 1
Next Episode: GU Podcast (2020) - Immune Checkpoint Inhibitors In RCC
The Expanding Role of Immune Checkpoint Inhibitors in MIBC and NMIBC
At the conclusion of this activity, participants will be able to:
1. Recognize both historic and newer immunotherapy options in the treatment of bladder cancer.
2. Describe the mechanism of action of immunotherapy regimens.
3. Identify and manage the adverse events related to these agents.
This educational series is supported by independent educational grants from:
Astellas
AstraZeneca
Bristol Myers Squibb
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck
Pfizer, Inc
Sanofi Genzyme
UroGen Pharma, Inc.
CME Available: https://auau.auanet.org/node/29831